Overview

Update
Total Equity Funding
$16M in 3 Rounds from 4 Investors
Most Recent Funding
$2.1M Series B on May 9, 2011
Headquarters:
Berlin, Berlin
Description:
caprotec bioanalytics developed a proprietary capture protein technology to reduce the complexity of protein mixtures and samples.
Categories:
Health Care, Biotechnology, Medical
Website:
http://www.caprotec.com

Company Details

Update

caprotec bioanalytics has developed a ground-breaking, proprietary technology to reduce the complexity of protein mixtures and samples in a targeted and directed manner.

caprotec's Capture Compound Mass Spectrometry (CCMS) Technology is based on multifunctional small molecules (Capture Compoundsâ„¢) that are used to target, capture, and isolate proteins based on their functionality. For many applications, CCMS is clearly superior to shotgun approaches - thus addressing an unmet need in the proteomics community.

Funding Rounds (3) - $16M

Update
DateAmount / RoundValuationLead InvestorInvestors
May, 2011$2.1M / Series B0
May, 2010$5.1M / Series B4
Jan, 2008$8.8M / Series B3

Current Team (1)

Update

Offices/Locations (1)

Update
  • Headquarters

    Magnusstraße 11

    Berlin, Berlin 12489

    Germany

Images (1)

Update

Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos